Johnson & Johnson (JNJ) is a Top Dividend Stock Right Now: Should You Buy?

Company Overview - Johnson & Johnson (JNJ) is headquartered in New Brunswick and operates in the Medical sector, with a stock price change of 13.19% since the start of the year [3]. Dividend Information - The company currently pays a dividend of $1.30 per share, resulting in a dividend yield of 3.18%, which is higher than the Large Cap Pharmaceuticals industry's yield of 2.38% and the S&P 500's yield of 1.52% [3]. - Johnson & Johnson's annualized dividend of $5.20 has increased by 5.9% from the previous year, with an average annual increase of 5.37% over the last 5 years [4]. - The current payout ratio is 52%, indicating that the company paid out 52% of its trailing 12-month earnings per share as dividends [4]. Earnings Growth - The Zacks Consensus Estimate for 2025 earnings per share is $10.83, reflecting a year-over-year earnings growth rate of 8.52% [5]. Investment Appeal - Johnson & Johnson is considered an attractive dividend play and a compelling investment opportunity, currently holding a Zacks Rank of 2 (Buy) [6].